Oral Antiviral Treatment for Genital Herpes
For genital herpes, prescribe acyclovir, valacyclovir, or famciclovir—all three are equally effective, but valacyclovir offers the most convenient dosing with once or twice-daily regimens.
Treatment Approach Based on Clinical Scenario
For Episodic Treatment of Recurrent Outbreaks
When treating an active recurrence, choose one of these regimens 1:
Acyclovir options:
- 400 mg orally three times daily for 5 days, OR
- 200 mg orally five times daily for 5 days, OR
- 800 mg orally twice daily for 5 days
Valacyclovir:
- 500 mg orally twice daily for 5 days
Famciclovir:
- 125 mg orally twice daily for 5 days
Key timing consideration: Treatment must be initiated during the prodrome or within 1 day of lesion onset to provide meaningful benefit 1. Provide patients with a prescription they can fill in advance and keep on hand to enable immediate self-initiation at the first sign of symptoms.
For Daily Suppressive Therapy
Suppressive therapy is indicated for patients with frequent recurrences (≥6 episodes per year) and reduces recurrence frequency by ≥75% 1. Choose one of these regimens 1:
Acyclovir:
- 400 mg orally twice daily
Valacyclovir:
- 500 mg orally once daily, OR
- 1,000 mg orally once daily, OR
- 250 mg orally twice daily
Famciclovir:
- 250 mg orally twice daily
Important caveat: Valacyclovir 500 mg once daily is less effective in patients with very frequent recurrences (≥10 episodes per year)—use higher doses or twice-daily regimens in these patients 1.
Comparative Effectiveness
While the 1998 CDC guidelines state that valacyclovir and famciclovir are comparable to acyclovir in clinical outcomes 1, more recent head-to-head research suggests valacyclovir may have a slight edge over famciclovir for viral suppression. One 2006 comparative trial found HSV was detected on 1.3% of days with valacyclovir versus 3.2% with famciclovir 2. However, a 2014 Cochrane review found insufficient evidence to definitively rank the three drugs 3.
Practical Prescribing Considerations
Dosing convenience matters for adherence: Valacyclovir and famciclovir offer simpler dosing schedules than acyclovir, which is particularly important for prolonged suppressive therapy 1. Valacyclovir's once-daily option (1,000 mg) provides the most convenient regimen.
Long-term safety: Acyclovir has the longest safety track record with documented efficacy for up to 6 years of continuous use, while valacyclovir and famciclovir data extend to 1 year 1. However, this reflects study duration rather than safety concerns—no clinically significant acyclovir resistance emerges in immunocompetent patients on suppressive therapy 1.
Reassessment strategy: After 1 year of continuous suppressive therapy, discontinue treatment temporarily to reassess the patient's recurrence rate, as frequency naturally decreases over time in many patients 1.
Special Situations
Severe disease requiring hospitalization (disseminated infection, pneumonitis, hepatitis, meningitis, or encephalitis): Use IV acyclovir 5-10 mg/kg every 8 hours for 5-7 days or until clinical resolution 1.
HSV-2 meningitis: For first episode, use acyclovir 10 mg/kg IV every 8 hours until fever and headache resolve, then switch to valacyclovir 1 g three times daily to complete 14 days total. For recurrent HSV-2 meningitis, oral therapy may be used for the entire course 4. Note that valacyclovir 500 mg twice daily is insufficient for CNS penetration and is not recommended for meningitis suppression 4.
Common Pitfalls to Avoid
- Don't use topical acyclovir—it is substantially less effective than oral therapy 5
- Don't delay prescribing—provide patients with advance prescriptions for episodic therapy so they can self-initiate treatment immediately when symptoms begin
- Don't forget counseling—suppressive therapy reduces but does not eliminate asymptomatic viral shedding or transmission risk 1
- Don't continue indefinitely without reassessment—evaluate need for ongoing suppression after 1 year